Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

The effect of HIV infection, antiretroviral therapy on carotid intima-media thickness: A systematic review and meta-analysis.

Msoka TF, Van Guilder GP, van Furth M, Smulders Y, Meek SJ, Bartlett JA, Vissoci JRN, van Agtmael MA.

Life Sci. 2019 Oct 15;235:116851. doi: 10.1016/j.lfs.2019.116851. Epub 2019 Sep 6.

PMID:
31499070
2.

Airway surface liquid has innate antiviral activity that is reduced in cystic fibrosis.

Berkebile AR, Bartlett JA, Abou Alaiwa M, Varga SM, Power UF, McCray PB Jr.

Am J Respir Cell Mol Biol. 2019 Jun 26. doi: 10.1165/rcmb.2018-0304OC. [Epub ahead of print]

PMID:
31242392
3.

Monitoring microsphere coating processes using PAT tools in a bench scale fluid bed.

Santos Silva B, Colbert MJ, Santangelo M, Bartlett JA, Lapointe-Garant PP, Simard JS, Gosselin R.

Eur J Pharm Sci. 2019 Jul 1;135:12-21. doi: 10.1016/j.ejps.2019.05.003. Epub 2019 May 5.

PMID:
31067496
4.

Building Process Understanding of Fluid Bed Taste Mask Coating of Microspheres.

Silva BS, Santangelo M, Colbert MJ, Fauteux-Lefebvre C, Bartlett JA, Lapointe-Garant PP, Gosselin R.

AAPS PharmSciTech. 2019 Apr 24;20(5):173. doi: 10.1208/s12249-019-1384-1.

PMID:
31020426
5.

Correction to: Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study.

Msoka TF, Van Guilder GP, Smulders YM, van Furth M, Bartlett JA, van Agtmael MA.

BMC Infect Dis. 2019 Feb 22;19(1):187. doi: 10.1186/s12879-019-3728-6.

6.

Cancer disparities in people with HIV: A systematic review of screening for non-AIDS-defining malignancies.

Corrigan KL, Wall KC, Bartlett JA, Suneja G.

Cancer. 2019 Mar 15;125(6):843-853. doi: 10.1002/cncr.31838. Epub 2019 Jan 15. Review.

7.

Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study.

Msoka TF, Van Guilder GP, Smulders YM, van Furth M, Bartlett JA, van Agtmael MA.

BMC Infect Dis. 2018 Dec 29;18(1):708. doi: 10.1186/s12879-018-3637-0. Erratum in: BMC Infect Dis. 2019 Feb 22;19(1):187.

8.

Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania.

Semvua SK, Orrell C, Mmbaga BT, Semvua HH, Bartlett JA, Boulle AA.

PLoS One. 2017 Dec 18;12(12):e0189460. doi: 10.1371/journal.pone.0189460. eCollection 2017.

9.

Partnership Conference.

Bartlett JA, Cao S, Mmbaga B, Qian X, Merson M, Kramer R.

Ann Glob Health. 2017 May - Aug;83(3-4):630-636. doi: 10.1016/j.aogh.2017.08.002. Epub 2017 Sep 28.

10.

Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop.

Ternik R, Liu F, Bartlett JA, Khong YM, Thiam Tan DC, Dixit T, Wang S, Galella EA, Gao Z, Klein S.

Int J Pharm. 2018 Feb 5;536(2):570-581. doi: 10.1016/j.ijpharm.2017.08.088. Epub 2017 Aug 24.

PMID:
28844897
11.

HIV Resistance and Prevention of Mother-to-Child Transmission Regimen in HIV-Infected Infants in Northern Tanzania.

Dow DE, Schimana W, Nyombi BM, Mmbaga BT, Shayo AM, Bartlett JA, Massambu CG, Kifaro EG, Turner EL, DeMarco T, Cai F, Cunningham CK, Buchanan AM.

AIDS Res Hum Retroviruses. 2017 Nov;33(11):1107-1113. doi: 10.1089/AID.2017.0025. Epub 2017 Oct 5.

12.

Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance.

Ramadhani HO, Muiruri C, Maro VP, Nyombi B, Omondi M, Mushi JB, Lirhunde ES, Bartlett JA.

AIDS Behav. 2018 May;22(5):1671-1678. doi: 10.1007/s10461-017-1721-x.

13.

Association of knowledge on ART line of treatment, scarcity of treatment options and adherence.

Ramadhani HO, Muiruri C, Maro VP, Omondi M, Mushi JB, Lirhunde ES, Bartlett JA.

BMC Health Serv Res. 2016 Jul 15;16:265. doi: 10.1186/s12913-016-1483-6.

14.

Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.

Borges ÁH, Lundh A, Tendal B, Bartlett JA, Clumeck N, Costagliola D, Daar ES, Echeverría P, Gisslén M, Huedo-Medina TB, Hughes MD, Huppler Hullsiek K, Khabo P, Komati S, Kumar P, Lockman S, MacArthur RD, Maggiolo F, Matteelli A, Miro JM, Oka S, Petoumenos K, Puls RL, Riddler SA, Sax PE, Sierra-Madero J, Torti C, Lundgren JD.

Clin Infect Dis. 2016 Jul 15;63(2):268-80. doi: 10.1093/cid/ciw236. Epub 2016 Apr 18. Review.

15.

Newborn Cystic Fibrosis Pigs Have a Blunted Early Response to an Inflammatory Stimulus.

Bartlett JA, Ramachandran S, Wohlford-Lenane CL, Barker CK, Pezzulo AA, Zabner J, Welsh MJ, Meyerholz DK, Stoltz DA, McCray PB Jr.

Am J Respir Crit Care Med. 2016 Oct 1;194(7):845-854.

16.

The Effect of Switching to Second-Line Antiretroviral Therapy on the Risk of Opportunistic Infections Among Patients Infected With Human Immunodeficiency Virus in Northern Tanzania.

Ramadhani HO, Bartlett JA, Thielman NM, Pence BW, Kimani SM, Maro VP, Mwako MS, Masaki LJ, Mmbando CE, Minja MG, Lirhunde ES, Miller WC.

Open Forum Infect Dis. 2016 Jan 29;3(1):ofw018. doi: 10.1093/ofid/ofw018. eCollection 2016 Jan.

17.

Enhancing future acceptance of rural placement in Tanzania through peripheral hospital rotations for medical students.

Kapanda GE, Muiruri C, Kulanga AT, Tarimo CN, Lisasi E, Mimano L, Mteta K, Bartlett JA.

BMC Med Educ. 2016 Feb 9;16:51. doi: 10.1186/s12909-016-0582-8.

18.

Development of an Instrument to Measure Civil and Uncivil Behaviors in the Hospital Clinical Environment: Implications for Nurse Leaders.

Tecza BM, Boots BK, Clay PM, Kirkman KS, Mains BC, Newton EE, Olney A, Bartlett JA.

J Nurs Adm. 2015 Jul-Aug;45(7-8):391-7. doi: 10.1097/NNA.0000000000000220.

PMID:
26204381
19.

IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16/18 vs. non-HPV16/18 genotypes.

Vidal AC, Skaar D, Maguire R, Dodor S, Musselwhite LW, Bartlett JA, Oneko O, Obure J, Mlay P, Murphy SK, Hoyo C.

Infect Agent Cancer. 2015 Mar 20;10:10. doi: 10.1186/s13027-015-0005-1. eCollection 2015.

20.

Increased susceptibility to otitis media in a Splunc1-deficient mouse model.

Bartlett JA, Meyerholz DK, Wohlford-Lenane CL, Naumann PW, Salzman NH, McCray PB Jr.

Dis Model Mech. 2015 May;8(5):501-8. doi: 10.1242/dmm.019646. Epub 2015 Mar 12.

21.

Association of first-line and second-line antiretroviral therapy adherence.

Ramadhani HO, Bartlett JA, Thielman NM, Pence BW, Kimani SM, Maro VP, Mwako MS, Masaki LJ, Mmbando CE, Minja MG, Lirhunde ES, Miller WC.

Open Forum Infect Dis. 2014 Sep 9;1(2):ofu079. doi: 10.1093/ofid/ofu079. eCollection 2014 Sep.

22.

Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.

Kumarasamy N, Aga E, Ribaudo HJ, Wallis CL, Katzenstein DA, Stevens WS, Norton MR, Klingman KL, Hosseinipour MC, Crump JA, Supparatpinyo K, Badal-Faesen S, Bartlett JA.

Clin Infect Dis. 2015 May 15;60(10):1552-8. doi: 10.1093/cid/civ109. Epub 2015 Feb 18.

23.

Summary report of PQRI Workshop on Nanomaterial in Drug Products: current experience and management of potential risks.

Bartlett JA, Brewster M, Brown P, Cabral-Lilly D, Cruz CN, David R, Eickhoff WM, Haubenreisser S, Jacobs A, Malinoski F, Morefield E, Nalubola R, Prud'homme RK, Sadrieh N, Sayes CM, Shahbazian H, Subbarao N, Tamarkin L, Tyner K, Uppoor R, Whittaker-Caulk M, Zamboni W.

AAPS J. 2015 Jan;17(1):44-64. doi: 10.1208/s12248-014-9701-9. Epub 2014 Nov 25.

25.

Initiation of antiretroviral therapy in HIV-infected adults with skin complaints in northern Tanzania.

Mavura DR, Masenga EJ, Minja E, Grossmann H, Crump JA, Bartlett JA.

Int J Dermatol. 2015 Jan;54(1):68-73. doi: 10.1111/ijd.12563. Epub 2014 Sep 26.

26.

Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV.

Dow DE, Bartlett JA.

Infect Dis Ther. 2014 Dec;3(2):83-102. doi: 10.1007/s40121-014-0029-7. Epub 2014 Jun 24. Review.

27.

miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production.

Weldon S, McNally P, McAuley DF, Oglesby IK, Wohlford-Lenane CL, Bartlett JA, Scott CJ, McElvaney NG, Greene CM, McCray PB Jr, Taggart CC.

Am J Respir Crit Care Med. 2014 Jul 15;190(2):165-74. doi: 10.1164/rccm.201311-1986OC.

28.

Nasogastric tube placement and verification in children: review of the current literature.

Irving SY, Lyman B, Northington L, Bartlett JA, Kemper C; NOVEL Project Work Group.

Nutr Clin Pract. 2014 Jun;29(3):267-76. doi: 10.1177/0884533614531456. Epub 2014 Apr 15. Review.

PMID:
24737681
29.

Nasogastric tube placement and verification in children: review of the current literature.

Irving SY, Lyman B, Northington L, Bartlett JA, Kemper C; Novel Project Work Group.

Crit Care Nurse. 2014 Jun;34(3):67-78. doi: 10.4037/ccn2014606. Epub 2014 Apr 15. Review.

30.

A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern Tanzania.

Reddy EA, Njau BN, Morpeth SC, Lancaster KE, Tribble AC, Maro VP, Msuya LJ, Morrissey AB, Kibiki GS, Thielman NM, Cunningham CK, Schimana W, Shao JF, Chow SC, Stout JE, Crump JA, Bartlett JA, Hamilton CD.

BMC Infect Dis. 2014 Feb 20;14:89. doi: 10.1186/1471-2334-14-89.

31.

Progress in the prevention of mother to child transmission of HIV in three regions of Tanzania: a retrospective analysis.

Buchanan AM, Dow DE, Massambu CG, Nyombi B, Shayo A, Musoke R, Feng S, Bartlett JA, Cunningham CK, Schimana W.

PLoS One. 2014 Feb 13;9(2):e88679. doi: 10.1371/journal.pone.0088679. eCollection 2014.

32.

Lack of protease inhibitor resistance following treatment failure--too good to be true?

Bartlett JA.

J Clin Invest. 2013 Sep;123(9):3704-5. doi: 10.1172/JCI71784. Epub 2013 Aug 27.

33.

Etiology of severe non-malaria febrile illness in Northern Tanzania: a prospective cohort study.

Crump JA, Morrissey AB, Nicholson WL, Massung RF, Stoddard RA, Galloway RL, Ooi EE, Maro VP, Saganda W, Kinabo GD, Muiruri C, Bartlett JA.

PLoS Negl Trop Dis. 2013 Jul 18;7(7):e2324. doi: 10.1371/journal.pntd.0002324. Print 2013.

34.

Chest radiography for predicting the cause of febrile illness among inpatients in Moshi, Tanzania.

Fiorillo SP, Diefenthal HC, Goodman PC, Ramadhani HO, Njau BN, Morrissey AB, Maro VP, Saganda W, Kinabo GD, Mwako MS, Bartlett JA, Crump JA.

Clin Radiol. 2013 Oct;68(10):1039-46. doi: 10.1016/j.crad.2013.05.002. Epub 2013 Jun 26.

35.

PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.

Vidal AC, Henry NM, Murphy SK, Oneko O, Nye M, Bartlett JA, Overcash F, Huang Z, Wang F, Mlay P, Obure J, Smith J, Vasquez B, Swai B, Hernandez B, Hoyo C.

Clin Transl Oncol. 2014 Mar;16(3):266-72. doi: 10.1007/s12094-013-1067-4. Epub 2013 Jun 18.

36.

Protein composition of bronchoalveolar lavage fluid and airway surface liquid from newborn pigs.

Bartlett JA, Albertolle ME, Wohlford-Lenane C, Pezzulo AA, Zabner J, Niles RK, Fisher SJ, McCray PB Jr, Williams KE.

Am J Physiol Lung Cell Mol Physiol. 2013 Aug 1;305(3):L256-66. doi: 10.1152/ajplung.00056.2013. Epub 2013 May 24.

37.

Increasing organizational evidence based practice capacity through an evidence based practice scholars program.

Bartlett JA, Allen NH.

J Pediatr Nurs. 2013 Jul-Aug;28(4):413-4. doi: 10.1016/j.pedn.2013.04.003. Epub 2013 May 8. Review. No abstract available.

PMID:
23665260
38.

Integrating routine HIV screening into a primary care setting in rural North Carolina.

Harmon JL, Collins-Ogle M, Bartlett JA, Thompson J, Barroso J.

J Assoc Nurses AIDS Care. 2014 Jan-Feb;25(1):70-82. doi: 10.1016/j.jana.2013.01.001. Epub 2013 Apr 9.

39.

SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection.

Liu Y, Bartlett JA, Di ME, Bomberger JM, Chan YR, Gakhar L, Mallampalli RK, McCray PB Jr, Di YP.

Am J Pathol. 2013 May;182(5):1519-31. doi: 10.1016/j.ajpath.2013.01.050. Epub 2013 Mar 15.

40.

Associations between methylation of paternally expressed gene 3 (PEG3), cervical intraepithelial neoplasia and invasive cervical cancer.

Nye MD, Hoyo C, Huang Z, Vidal AC, Wang F, Overcash F, Smith JS, Vasquez B, Hernandez B, Swai B, Oneko O, Mlay P, Obure J, Gammon MD, Bartlett JA, Murphy SK.

PLoS One. 2013;8(2):e56325. doi: 10.1371/journal.pone.0056325. Epub 2013 Feb 13.

41.

Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa.

Phillips E, Bartlett JA, Sanne I, Lederman MM, Hinkle J, Rousseau F, Dunn D, Pavlos R, James I, Mallal SA, Haas DW.

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):e55-7. doi: 10.1097/QAI.0b013e31827ca50f. No abstract available.

42.

Psychometric evaluation of the Shared Decision-Making Instrument--Revised.

Bartlett JA, Peterson JA.

West J Nurs Res. 2013 Feb;35(2):193-213. doi: 10.1177/0193945912463267. Epub 2012 Nov 26.

PMID:
23188669
43.

Brucellosis among hospitalized febrile patients in northern Tanzania.

Bouley AJ, Biggs HM, Stoddard RA, Morrissey AB, Bartlett JA, Afwamba IA, Maro VP, Kinabo GD, Saganda W, Cleaveland S, Crump JA.

Am J Trop Med Hyg. 2012 Dec;87(6):1105-11. doi: 10.4269/ajtmh.2012.12-0327. Epub 2012 Oct 22.

44.

Understanding the oral mucosal absorption and resulting clinical pharmacokinetics of asenapine.

Bartlett JA, van der Voort Maarschalk K.

AAPS PharmSciTech. 2012 Dec;13(4):1110-5. doi: 10.1208/s12249-012-9839-7. Epub 2012 Aug 31.

45.

Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study.

Crump JA, Ramadhani HO, Morrissey AB, Saganda W, Mwako MS, Yang LY, Chow SC, Njau BN, Mushi GS, Maro VP, Reller LB, Bartlett JA.

Clin Infect Dis. 2012 Jul;55(2):242-50. doi: 10.1093/cid/cis409. Epub 2012 Apr 16.

46.

Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.

Bartlett JA, Ribaudo HJ, Wallis CL, Aga E, Katzenstein DA, Stevens WS, Norton MR, Klingman KL, Hosseinipour MC, Crump JA, Supparatpinyo K, Badal-Faesen S, Kallungal BA, Kumarasamy N.

AIDS. 2012 Jul 17;26(11):1345-54. doi: 10.1097/QAD.0b013e328353b066.

47.

Chikungunya and dengue fever among hospitalized febrile patients in northern Tanzania.

Hertz JT, Munishi OM, Ooi EE, Howe S, Lim WY, Chow A, Morrissey AB, Bartlett JA, Onyango JJ, Maro VP, Kinabo GD, Saganda W, Gubler DJ, Crump JA.

Am J Trop Med Hyg. 2012 Jan;86(1):171-7. doi: 10.4269/ajtmh.2012.11-0393.

48.

Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women.

Vidal AC, Murphy SK, Hernandez BY, Vasquez B, Bartlett JA, Oneko O, Mlay P, Obure J, Overcash F, Smith JS, van der Kolk M, Hoyo C.

Infect Agent Cancer. 2011 Nov 14;6(1):20. doi: 10.1186/1750-9378-6-20.

49.

Quantitation of SPLUNC1 in saliva with an xMAP particle-based antibody capture and detection immunoassay.

Kohlgraf KG, Ackermann AR, Burnell KK, Srikantha RN, Joly SA, Bartlett JA, Gakhar L, Johnson GK, McCray PB Jr, Guthmiller JM, Brogden KA.

Arch Oral Biol. 2012 Feb;57(2):197-204. doi: 10.1016/j.archoralbio.2011.08.013. Epub 2011 Sep 16.

50.

Leptospirosis among hospitalized febrile patients in northern Tanzania.

Biggs HM, Bui DM, Galloway RL, Stoddard RA, Shadomy SV, Morrissey AB, Bartlett JA, Onyango JJ, Maro VP, Kinabo GD, Saganda W, Crump JA.

Am J Trop Med Hyg. 2011 Aug;85(2):275-81. doi: 10.4269/ajtmh.2011.11-0176.

Supplemental Content

Loading ...
Support Center